QuidelOrtho Corporation (QDEL) Cash Flow Statement
QuidelOrtho Corporation (QDEL) generated -$57.2M of operating cash flow over the twelve months to 2026-06-30, spent $154.0M on capital expenditure and had free cash flow of -$211.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
QDELQuidelOrtho CorporationFollow QDEL — free
—
Price chart with a free account
- Market cap
- 941.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 9 days
| Line | FY2022 Jan 23 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Operating cash flow | 0.89 | 0.28 | 0.08 | 0.11 | -0.06 | |
| Capital expenditure | 0.14 | 0.21 | 0.20 | 0.19 | -0.15 | |
| Free cash flow | 0.74 | 0.07 | -0.11 | -0.08 | -0.21 | |
| Share repurchases | 0.07 | 0.01 | 0.00 | 0.00 | — | |
| Stock-based compensation | 0.05 | 0.05 | 0.04 | 0.05 | — |
USD billions · SEC XBRL
QuidelOrtho Corporation — questions
- What is QuidelOrtho Corporation's operating cash flow?
- -$57.2M over the twelve months to 2026-06-30.
- How much does QuidelOrtho Corporation spend on capital expenditure?
- $154.0M over the twelve months to 2026-06-30.
- What is QuidelOrtho Corporation's free cash flow?
- -$211.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from QuidelOrtho Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.